Literature DB >> 27514292

Pre-eclampsia and risk of infantile haemangioma.

N Auger1,2, W D Fraser3, L Arbour4, J Healy-Profitós1,2, B A Drolet5.   

Abstract

BACKGROUND: Infantile haemangioma is the most common tumour of infancy, but the association with pre-eclampsia is poorly understood.
OBJECTIVES: We determined the relationship between variants of pre-eclampsia and risk of infantile haemangioma.
METHODS: We carried out a retrospective cohort study of hospital data for all live births between 1989 and 2013 in Quebec, Canada. We identified 14 240 neonates with, and 1 930 564 without haemangioma before discharge, and determined whether early- or late-onset pre-eclampsia was documented on the maternal chart. We used log-binomial regression to compute prevalence ratios (PRs) and 95% confidence intervals (CIs) for the association between pre-eclampsia and infantile haemangioma, adjusted for maternal characteristics.
RESULTS: The prevalence of any haemangioma was higher for pre-eclampsia than for no pre-eclampsia (81·3 vs. 72·9 per 10 000), with a PR of 1·15 (95% CI 1·06-1·25) after adjustment for maternal characteristics. Pre-eclampsia with onset before 34 weeks' gestation was associated with cutaneous (PR 2·32, 95% CI 1·68-3·21), noncutaneous (PR 3·66, 95% CI 2·49-5·37) and unspecified haemangioma (PR 2·49, 95% CI 1·77-3·49). However, the association between early-onset pre-eclampsia and haemangioma was attenuated once long neonatal length of hospital stays was accounted for. There was no association with late-onset pre-eclampsia after 34 weeks, and associations were weaker for other variants including severe pre-eclampsia and pre-eclampsia with low birthweight.
CONCLUSIONS: Early-onset pre-eclampsia is associated with increased risk of haemangioma at birth, but detection bias due to longer hospital stays and closer follow-up may be part of the reason.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 27514292     DOI: 10.1111/bjd.14958

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.

Authors:  Xue Gong; Tong Qiu; Liwei Feng; Kaiying Yang; Shiyi Dai; Jiangyuan Zhou; Xuepeng Zhang; Siyuan Chen; Yi Ji
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-25

2.  Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis.

Authors:  Bin Xie; Xiongming Zhou; Jiaxuan Qiu
Journal:  BMC Pediatr       Date:  2022-05-01       Impact factor: 2.567

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.